Form 4 for BJDX Bluejay Diagnostics, Inc.
Accepted 2026-08-18 16:15:35 ET · period of report 2026-08-17 · accession 0001123292-26-001124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 16:15 | 2026-08-17 | BJDX | Dey Indranil | Pres, CEO, Dir | A - Grant | $0.00 | +28.0K | 40.5K | +224% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-17 | A | A | 28,000 | $0.00 | 40,522 | D | — | — | (F1) These shares represent restricted stock units granted by the board of directors of the issuer. |